Health Condition 1: L400- Psoriasis vulgaris
Conditions
Interventions
Intervention1: topical calcipotriol plus NBUVB: topical calcipotriol to be applied on right side along with NBUVB thrice per week
Control Intervention1: Topical calcitriol plus NBUVB: topical calcitri
Sponsors
Kamal Aggarwal
Eligibility
Inclusion criteria
Inclusion criteria: Patients with stable plaque psoriasis not exceeding 50% of body surface area involvement of age more than 18 years, according to the rule of nine, was included in this study.
Exclusion criteria
Exclusion criteria: • Patients of age 18 years and below. • Patients who have used systemic antipsoriatic treatment or phototherapy within 2 months prior to the study. • Patients having intolerance or previous failure to phototherapy. • Patients using phototoxic drugs or drugs influencing psoriasis (lithium, beta blockers etc). • Patients with hypersensitivity to calcipotriol or calcitriol. • Patients with known hypercalcemia or hypersensitivity to calcipotriol. • Patients with a history suggestive of photosensitivity or polymorphic light eruptions. • Patients with previous or current carcinoma of the skin or actinic keratosis. • Pregnant patients or lactating mothers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare efficacy between topical calcipotriol and topical calcitriolTimepoint: to compare the difference of calcipotriol and calcitriol over 12 week period | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the safety of the two combinations by assessing the adverse effects.Timepoint: 1 year | — |
Countries
India
Contacts
Public ContactDr Kamal Aggarwal
PT BD Sharma PGIMS Rohtak
Outcome results
None listed